Natera (NTRA) Competitors

Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation, institutional ownership and community ranking.

Do analysts rate NTRA or FMS?

Natera currently has a consensus target price of $178.12, suggesting a potential upside of 15.23%. Fresenius Medical Care has a consensus target price of $25.30, suggesting a potential upside of 3.48%. Given Natera's stronger consensus rating and higher possible upside, equities research analysts clearly believe Natera is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has more volatility & risk, NTRA or FMS?

Natera has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Does the media refer more to NTRA or FMS?

In the previous week, Natera had 19 more articles in the media than Fresenius Medical Care. MarketBeat recorded 25 mentions for Natera and 6 mentions for Fresenius Medical Care. Natera's average media sentiment score of 0.98 beat Fresenius Medical Care's score of 0.81 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	16 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has stronger valuation & earnings, NTRA or FMS?

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$1.70B	12.31	-$434.80M	-$1.53	-101.03
Fresenius Medical Care	$19.34B	0.74	$540.07M	$0.99	24.70

Do institutionals & insiders have more ownership in NTRA or FMS?

99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 7.6% of Natera shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor NTRA or FMS?

Natera received 67 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.92% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Natera	Outperform Votes 490 68.92%	Underperform Votes 221 31.08%
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%

Is NTRA or FMS more profitable?

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-14.01%	-26.23%	-14.27%
Fresenius Medical Care	3.43%	6.04%	2.69%

Summary

Natera beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.